KEGG   DISEASE: Phosphoserine aminotransferase deficiency
Entry
H01082                      Disease                                
Name
Phosphoserine aminotransferase deficiency
Description
Phosphoserine aminotransferase (PSAT) deficiency is a disorder of serine biosynthesis characterized biochemically by low plasma and CSF concentrations of serine and glycine and clinically by intractable seizures, acquired microcephaly, hypertonia, and psychomotor retardation. The biochemical and clinical features of PSAT deficiency shared some of the features of 3-PGDH deficiency [DS:H01079]. Mutations in the PSAT1 gene have been identified.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Inborn errors of metabolism
    5C50  Inborn errors of amino acid or other organic acid metabolism
     H01082  Phosphoserine aminotransferase deficiency
Pathway-based classification of diseases [BR:br08402]
 Amino acid metabolism
  nt06033  Glycine, serine and arginine metabolism
   H01082  Phosphoserine aminotransferase deficiency
Pathway
hsa01230  Biosynthesis of amino acids
hsa00260  Glycine, serine and threonine metabolism
hsa00750  Vitamin B6 metabolism
Network
nt06033 Glycine, serine and arginine metabolism
Gene
PSAT1 [HSA:29968] [KO:K00831]
Other DBs
ICD-11: 5C50.6
MeSH: C567032
OMIM: 610992
Reference
  Authors
Hart CE, Race V, Achouri Y, Wiame E, Sharrard M, Olpin SE, Watkinson J, Bonham JR, Jaeken J, Matthijs G, Van Schaftingen E
  Title
Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway.
  Journal
Am J Hum Genet 80:931-7 (2007)
DOI:10.1086/517888
Reference
  Authors
Tabatabaie L, Klomp LW, Berger R, de Koning TJ
  Title
L-serine synthesis in the central nervous system: a review on serine deficiency disorders.
  Journal
Mol Genet Metab 99:256-62 (2010)
DOI:10.1016/j.ymgme.2009.10.012
LinkDB

» Japanese version

KEGG   DISEASE: Neu-Laxova syndrome
Entry
H02117                      Disease                                
Name
Neu-Laxova syndrome
Description
Neu-Laxova syndrome (NLS) is an autosomal recessive multiple malformation syndrome characterized by a recognizable pattern of severe malformations leading to prenatal or early postnatal lethality. It is characterized by ichthyosis, marked intrauterine growth restriction (IUGR), microcephaly, short neck, central nervous system anomalies, limb deformities, hypoplastic lungs, edema, and abnormal facial features. NLS is genetically heterogeneous and can be caused by mutations in the genes encoding enzymes of the L-serine biosynthesis pathway.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 20 Developmental anomalies
  Multiple developmental anomalies or syndromes
   LD20  Syndromes with central nervous system anomalies as a major feature
    H02117  Neu-Laxova syndrome
Pathway-based classification of diseases [BR:br08402]
 Amino acid metabolism
  nt06033  Glycine, serine and arginine metabolism
   H02117  Neu-Laxova syndrome
Pathway
hsa00260  Glycine, serine and threonine metabolism
hsa00750  Vitamin B6 metabolism
Network
nt06033 Glycine, serine and arginine metabolism
Gene
PHGDH [HSA:26227] [KO:K00058]
PSAT1 [HSA:29968] [KO:K00831]
Comment
See also H01079, H01082, and H02116.
Other DBs
ICD-11: LD20.1
MeSH: C536405
OMIM: 256520 616038
Reference
PMID:5547878
  Authors
Neu RL, Kajii T, Gardner LI, Nagyfy SF
  Title
A lethal syndrome of microcephaly with multiple congenital anomalies in three siblings.
  Journal
Pediatrics 47:610-2 (1971)
Reference
  Authors
Manning MA, Cunniff CM, Colby CE, El-Sayed YY, Hoyme HE
  Title
Neu-Laxova syndrome: detailed prenatal diagnostic and post-mortem findings and literature review.
  Journal
Am J Med Genet A 125A:240-9 (2004)
DOI:10.1002/ajmg.a.20467
Reference
  Authors
Shaheen R, Rahbeeni Z, Alhashem A, Faqeih E, Zhao Q, Xiong Y, Almoisheer A, Al-Qattan SM, Almadani HA, Al-Onazi N, Al-Baqawi BS, Saleh MA, Alkuraya FS
  Title
Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH.
  Journal
Am J Hum Genet 94:898-904 (2014)
DOI:10.1016/j.ajhg.2014.04.015
Reference
  Authors
Acuna-Hidalgo R, Schanze D, Kariminejad A, Nordgren A, Kariminejad MH, Conner P, Grigelioniene G, Nilsson D, Nordenskjold M, Wedell A, Freyer C, Wredenberg A, Wieczorek D, Gillessen-Kaesbach G, Kayserili H, Elcioglu N, Ghaderi-Sohi S, Goodarzi P, Setayesh H, van de Vorst M, Steehouwer M, Pfundt R, Krabichler B, Curry C, MacKenzie MG, Boycott KM, Gilissen C, Janecke AR, Hoischen A, Zenker M
  Title
Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway.
  Journal
Am J Hum Genet 95:285-93 (2014)
DOI:10.1016/j.ajhg.2014.07.012
LinkDB

» Japanese version

DBGET integrated database retrieval system